 Eloxx Pharmaceuticals NASDAQ: ELOX shares are trading higher on Thursday.The company announced that enrollment in its Phase 2 trial for ELX-02 has resumed in Israel and Europe. It was on pause due to the Covid-19 pandemic.Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid RNA-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases.The ELX-02, the companys lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinos.Eloxx Pharmaceuticals shares were trading up 16.89 at 3.56 at time of publication on Thursday. The stock has a 52-week high of 10.01 and a 52-week low of 1.44.See more from Benzinga Why Adamas Pharmaceuticals Is Trading Lower Today Why Dada Nexus Stock Is Trading Higher Today Why Sonos Stock Is Trading Lower TodayC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 